tiprankstipranks
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market
BBLG
Bone Biologics
RESEARCH TOOLSreports
Want to see BBLG full AI Analyst Report?

Bone Biologics (BBLG) Income Statement

93 Followers

Bone Biologics Income Statement

Last quarter (Q4 2025), Bone Biologics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Bone Biologics's net income was $-684.64K. See Bone Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 3.23M$ 4.22M$ 9.43M$ 3.67M$ 1.10M
Depreciation and Amortization
$ 0.00$ 4.22M$ 9.43M$ 0.00$ 0.00
EBITDA
$ -3.11M$ 107.16K$ 479.57K$ -752.91K$ -805.58K
Operating Income
$ -3.23M$ -4.22M$ -9.43M$ -3.67M$ -1.10M
Other Income/Expenses
$ 125.95K$ 106.74K$ 479.57K$ 2.18M$ -507.61K
Pretax Income
$ -3.11M$ -4.11M$ -8.95M$ -1.48M$ -1.61M
Net Income
$ -3.11M$ -4.11M$ -8.95M$ -1.48M$ -1.61M
Per Share Metrics
Basic EPS
$ -2.65$ -4.83$ -34.01$ -31.15$ -37.35
Diluted EPS
$ -2.65$ -4.83$ -34.01$ -31.20$ -37.35
Weighted Average Shares Outstanding
 1.17M 1.52M 263.14K 47.60K 43.00K
Weighted Average Shares Outstanding (Diluted)
 1.17M 1.52M 263.14K 47.66K 43.13K
Currency in USD

Bone Biologics Earnings and Revenue History